Clinical and Experimental Immunomodulation 2014
نویسندگان
چکیده
منابع مشابه
Clinical and Experimental Immunomodulation 2014
1Department of Psychoimmunology, National Institute of Psychiatry “Ramón de la Fuente”, Calzada México-Xochimilco 101, Colonia San Lorenzo Huipulco, Tlalpan, 14370 Mexico City, DF, Mexico 2Instituto de Inmunologı́a, Facultad de CienciasMédicas, UniversidadNacional de Rosario, Santa Fe 3100 CP, 2000 Rosario, Argentina 3Research Group Immunophysiology, Institute of Physiology and Pathophysiology, ...
متن کاملClinical and Experimental Immunomodulation
1 Department of Psychoimmunology, National Institute of Psychiatry “Ramón de la Fuente”, Calzada México-Xochimilco 101, Colonia San Lorenzo Huipulco, Tlalpan, 14370 Mexico City, DF, Mexico 2 Research Group Immunophysiology, Institute of Physiology and Pathophysiology, Philipps University, 35037 Marburg, Germany 3 Instituto de Inmunologı́a, Facultad de CienciasMédicas, UniversidadNacional de Rosa...
متن کاملClinical and Experimental Immunomodulation 2016
1Department of Psychoimmunology, National Institute of Psychiatry “Ramón de la Fuente”, Calzada México-Xochimilco 101, Colonia San Lorenzo Huipulco, Tlalpan, 14370 Mexico City, Mexico 2Research Group Immunophysiology, Institute of Physiology and Pathophysiology, Philipps University, 35037 Marburg, Germany 3Instituto de Inmunologı́a Cĺınica y Experimental, CONICET-Universidad Nacional de Rosario,...
متن کاملClinical and experimental scleroderma 2014.
Prof. Alan Tyndall, Secretary, World Scleroderma Foundation, Basel, Switzerland; Ann Tyrrell Kennedy, President, FESCA, Blackrock, Co. Dublin, Ireland; Prof. Dinesh Khanna, Director, University of Michigan Scleroderma Program, Ann Arbor, MI, USA; Prof. Yannick Allanore, President, EUSTAR, Paris Descartes University, Rheumatology A department, Cochin Hospital, Paris, France. Please address corre...
متن کاملTransfusion-Associated Immunomodulation: Experimental Facts and Clinical Reality New Perspectives
Blood component transfusion may be required in association with emergency and chronic disease to improve hemodynamics and tissue oxygenation. Due to the risk of microbial transfection from donor to recipient, the blood is undergoing vigorous testing to improve safety. It is well known, however, that blood component transfusion may lead to certain acute side effects with a frequency of 0.5–2% de...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Immunology Research
سال: 2015
ISSN: 2314-8861,2314-7156
DOI: 10.1155/2015/758328